Revenla Tablet, Film Coated
Product Images NDC 87367-166
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Revenla (NDC 87367-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Insignamedex Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Dosage Forms And Strength (Sevelamer Carbonate Product Label)
This text contains information about a medication with the active ingredient Sevelamer carbonate at a dosage of 800 mg per tablet. The usual dosage instructions are available in the package insert. The tablets should be stored at controlled room temperature (between 59°F to 86°F) and protected from moisture. The medication is intended for prescription use only. The product was manufactured in China for InsignaMedex LLC and the revision date is 05/2026.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.